within Pharmacolibrary.Drugs.ATC.R;

model R06AA09
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.815,
    Cl             = 5.833333333333333e-05,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R06AA09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Doxylamine is a first-generation antihistamine belonging to the ethanolamine class. It is primarily used as a short-term treatment for insomnia and as a nighttime sleep aid. Doxylamine is also found in combination with other agents as an ingredient for relief of symptoms of allergy, common cold, or as part of antiemetic preparations. It is approved and marketed in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers; oral tablet administration.</p><h4>References</h4><ol><li><p>Luna, BG, et al., &amp; Greenblatt, DJ (1989). Doxylamine and diphenhydramine pharmacokinetics in women on low-dose estrogen oral contraceptives. <i>Journal of clinical pharmacology</i> 29(3) 257–260. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1989.tb03323.x&quot;>10.1002/j.1552-4604.1989.tb03323.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2723113/&quot;>https://pubmed.ncbi.nlm.nih.gov/2723113</a></p></li><li><p>Balan, G, et al., &amp; Seeck, M (2013). Doxylamine pharmacokinetics following single dose oral administration in children ages 2-17 years. <i>Journal of clinical pharmacology</i> 53(11) 1177–1185. DOI:<a href=&quot;https://doi.org/10.1002/jcph.137&quot;>10.1002/jcph.137</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23868556/&quot;>https://pubmed.ncbi.nlm.nih.gov/23868556</a></p></li><li><p>Pelser, A, et al., &amp; Goosen, C (2002). Comparative pharmacokinetics of single doses of doxylamine succinate following intranasal, oral and intravenous administration in rats. <i>Biopharmaceutics &amp; drug disposition</i> 23(6) 239–244. DOI:<a href=&quot;https://doi.org/10.1002/bdd.314&quot;>10.1002/bdd.314</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12214324/&quot;>https://pubmed.ncbi.nlm.nih.gov/12214324</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R06AA09;
